English EN Spanish ES French FR Chinese (Simplified) ZH-CN

Scott Rowley, MD

Board Certifications: Hematology, Internal Medicine and Medical Oncology

Specializations: T-Cell Therapy

Languages: English

Locations: Hackensack, NJ

Dr. Scott D. Rowley specializes in medical oncology, hematology, and stem cell transplantation. He is actively involved in stem cell transplantation research.

Education

Medical Education

The University of Massachusetts Medical School

Residency

Internal medicine, Rhode Island Hospital

fellowship

Medical oncology/hematology, Johns Hopkins Hospital

Awards and honors

Awards and honors

  • America’s Top Doctors (book series): 10th Edition, 11th Edition, 12th Edition, 13th Edition, 14th Edition, 9th Edition
  • Top Doctors: New York Metro Area (book series): 12th Edition, 13th Edition, 14th Edition, 15th Edition, 16th Edition, 17th Edition, 18th Edition
  • New York Magazine: Top Doctors: 2009, 2010, 2011, 2012, 2013, 2020, 2021
  • America’s Top Doctors for Cancer (book series): 10th Edition, 5th Edition, 6th Edition, 7th Edition, 8th Edition, 9th Edition
  • Jersey’s Best Magazine Top Doctors: 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020
  • Jersey’s Best – Top Doctors for Cancer: 2012
  • Newsweek: 2015
  • Castle Connolly America’s Top Doctors (digital guide): 2016, 2017, 2018, 2019, 2020, 2021
  • Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021
  • Castle Connolly America’s Top Doctors for Cancer (digital guide): 2016, 2017, 2018, 2019, 2020, 2021

Professional Memberships

memberships

Hospital Affiliations

John Theurer Cancer Center, Hackensack University Medical Center

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.